Showing results (141-150 of 160) with videos related to

Sort By:
Pageof 16
Translational Oncology|October 5, 2023
Gene partners of the EWSR1 fusion may represent molecularly distinct entitiesVictoria Walker, Dexter X Jin, Sherri Z Millis, et al.
The Oncologist|December 14, 2018
BRCA1/2 Functional Loss Defines a Targetable Subset in LeiomyosarcomaNathan D Seligson, Esko A Kautto, Edward N Passen, et al.
Clinical Orthopaedics and Related Research|October 1, 1993
Comparison of the clinical efficacy and tolerance of gentamicin PMMA beads on surgical wire versus combined and systemic therapy for osteomyelitisJ D Blaha, J H Calhoun, C L Nelson, et al.
NPJ Precision Oncology|April 26, 2022
Drivers of genomic loss of heterozygosity in leiomyosarcoma are distinct from carcinomasNathan D Seligson, Joy Tang, Dexter X Jin, et al.
Frontiers in Pharmacology|January 23, 2024
CYP3A5 influences oral tacrolimus pharmacokinetics and timing of acute kidney injury following allogeneic hematopoietic stem cell transplantationNathan D Seligson, Xunjie Zhang, Mark C Zemanek, et al.
Pharmacogenomics|July 29, 2025
From bench to bedside: a spotlight on pharmacogenomics at Nemours Children's HealthKelsey J Cook, Nathan D Seligson, Benjamin Q Duong, et al.
Cancers|April 3, 2021
UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical ImplementationRyan S Nelson, Nathan D Seligson, Sal Bottiglieri, et al.
Haematologica|March 2, 2023
PARP1 and POLD2 as prognostic biomarkers for multiple myeloma in autologous stem cell transplantMelissa Thomas, Junan Li, Kevan King, et al.
Clinical and Translational Science|July 7, 2023
Comparison of variants in TPMT and NUDT15 between sequencing and genotyping methods in a multistate pediatric institutionKelsey J Cook, Victoria Grusauskas, Lucy Gloe, et al.
Pageof 16